Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds

Inclusion Criteria: * Age ≥ 18 years * Patient is legally capable * Patient has signed written informed consent * Presence of one of the following wounds * Venous lower leg ulcer * Arterial ulcer * Diabetic ulcer * Pressure ulcer * Post-operative wound healing by secondary intention * Traumatic wound * Surgical wound * Burn or scald (grade III: after surgical debridement) * Epidermolysis Bullosa * Wound area \>4cm2 * The entire wound area can be displayed on one photo from a distance of 25-30 cm * Covered with at least 30% debris, necrosis, slough, fibrotic tissue Exclusion Criteria: * Known allergy and/or hypersensitivity to Debrisoft® Duo or any of the product components * Pregnancy or breast feeding * Patient is illiterate * Participation in a interventional clinical trial within the last 14 days and during participation in this study * Any other medical condition, which, by opinion of the investigator, may have impact of the success of the study treatment and/ or interpretation of the study results * severe pain or hyperesthesia in the wound area * history of drug or alcohol abuse * chronic analgesic use (especially opioids) that could influence baseline pain perception * cognitive impairment, which may affect the ability to accurately self-report pain * Use of anaesthesia before the debridment procedure * presence of hard necrotic tissue or other tissue which should not be debrided in general. Other types of hard necrotic tissue requiring debridemen…